help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ritter, M. M.
Right arrow Articles by Engelhardt, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ritter, M. M.
Right arrow Articles by Engelhardt, D.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 1035-1037, Copyright © 1996 by Endocrine Society


ARTICLES

Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease

MM Ritter, A Frilling, PA Crossey, W Hoppner, ER Maher, L Mulligan, BA Ponder and D Engelhardt
Medical Department II, Klinikum Grosshadern, University of Munich, Germany.

Inherited pheochromocytomas are often part of familial syndromes, especially multiple endocrine neoplasia type 2 (MEN 2), retinal cerebellar hemangioblastomatosis [von Hippel-Lindau (vHL) disease] or neurofibromatosis type 1. It is not clear whether isolated familial pheochromocytoma exists as a separate clinical entity. In a family with pheochromocytomas in three generations and with at least seven affected members, we investigated by clinical and genetic analyses the presence or absence of associated conditions. The clinical investigations included ophthalmological and radiological studies for von Hippel- Lindau disease (magnetic resonance imaging of the brain, computed tomography of the abdomen, and direct ophthalmoscopy after mydriasis) and annual calcitonin stimulation tests for C cell disease in five members who agreed to regular follow-up. Besides the pheochromocytomas (so far, these have been multiple in five of seven individuals) no definite second associated condition was found. Genetic analysis did not identify any MEN 2-specific RET protooncogene point mutations (which are present in 97% of MEN 2a families). However, despite the complete absence of other clinical manifestations of the vHL disease (besides pheochromocytomas), a previously undescribed germline missense mutation in the vHL tumor suppressor gene was found (C775G transversion with a predicted substitution of a leucine by a valine at codon 259 in the putative vHL protein). We conclude that in this family the sole occurrence of pheochromocytoma is a variant of vHL disease.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Knauth, E. Cartwright, S. Freund, M. Bycroft, and A. Buchberger
VHL Mutations Linked to Type 2C von Hippel-Lindau Disease Cause Extensive Structural Perturbations in pVHL
J. Biol. Chem., April 17, 2009; 284(16): 10514 - 10522.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Gunaratnam, M. Morley, A. Franovic, N. de Paulsen, K. Mekhail, D. A. E. Parolin, E. Nakamura, I. A. J. Lorimer, and S. Lee
Hypoxia Inducible Factor Activates the Transforming Growth Factor-{alpha}/Epidermal Growth Factor Receptor Growth Stimulatory Pathway in VHL-/- Renal Cell Carcinoma Cells
J. Biol. Chem., November 7, 2003; 278(45): 44966 - 44974.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Weirich, B. Klein, T. Wohl, D. Engelhardt, and H. Brauch
VHL2C Phenotype in a German von Hippel-Lindau Family with Concurrent VHL Germline Mutations P81S and L188V
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5241 - 5246.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Dollfus, P. Massin, P. Taupin, C. Nemeth, S. Amara, S. Giraud, C. Beroud, P. Dureau, A. Gaudric, P. Landais, et al.
Retinal Hemangioblastoma in von Hippel-Lindau Disease: A Clinical and Molecular Study
Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3067 - 3074.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
B E Baysal
Hereditary paraganglioma targets diverse paraganglia
J. Med. Genet., September 1, 2002; 39(9): 617 - 622.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. A. Hoffman, M. Ohh, H. Yang, J. M. Klco, M. Ivan, and W. G. Kaelin Jr
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF
Hum. Mol. Genet., May 1, 2001; 10(10): 1019 - 1027.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Eisenhofer, M. M. Walther, T.-T. Huynh, S.-T. Li, S. R. Bornstein, A. Vortmeyer, M. Mannelli, D. S. Goldstein, W. M. Linehan, J. W. M. Lenders, et al.
Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1999 - 2008.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Brauch, W. Hoeppner, H. Jahnig, T. Wohl, D. Engelhardt, F. Spelsberg, and M. M. Ritter
Sporadic Pheochromocytomas Are Rarely Associated with Germline Mutations in the vhl Tumor Suppressor Gene or the ret Protooncogene
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4101 - 4104.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society